Natus Medical Inc (BABY) Shares Sold by First Mercantile Trust Co.
First Mercantile Trust Co. trimmed its stake in shares of Natus Medical Inc (NASDAQ:BABY) by 17.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,744 shares of the medical equipment provider’s stock after selling 2,207 shares during the quarter. First Mercantile Trust Co.’s holdings in Natus Medical were worth $410,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in BABY. Koch Industries Inc. boosted its position in Natus Medical by 7,423.5% during the second quarter. Koch Industries Inc. now owns 462,472 shares of the medical equipment provider’s stock worth $450,000 after purchasing an additional 456,325 shares during the period. Hillcrest Asset Management LLC bought a new position in Natus Medical during the third quarter worth $8,966,000. Cambiar Investors LLC bought a new position in Natus Medical during the fourth quarter worth $8,970,000. Dimensional Fund Advisors LP boosted its position in Natus Medical by 10.8% during the second quarter. Dimensional Fund Advisors LP now owns 1,552,938 shares of the medical equipment provider’s stock worth $57,924,000 after purchasing an additional 151,372 shares during the period. Finally, Broadfin Capital LLC bought a new position in Natus Medical during the second quarter worth $4,159,000. 93.91% of the stock is owned by hedge funds and other institutional investors.
In other news, Director William M. Moore sold 5,000 shares of Natus Medical stock in a transaction on Monday, November 13th. The stock was sold at an average price of $41.01, for a total transaction of $205,050.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 5.50% of the stock is currently owned by company insiders.
Natus Medical (NASDAQ:BABY) last posted its earnings results on Wednesday, February 7th. The medical equipment provider reported $0.42 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.54 by ($0.12). Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. The firm had revenue of $131.40 million for the quarter, compared to analyst estimates of $131.38 million. During the same period in the prior year, the business posted $0.51 EPS. The firm’s quarterly revenue was up 22.0% compared to the same quarter last year. research analysts forecast that Natus Medical Inc will post 1.63 EPS for the current fiscal year.
A number of equities analysts have commented on the stock. Benchmark reaffirmed a “buy” rating and set a $49.00 price objective (down from $55.00) on shares of Natus Medical in a research report on Tuesday, January 16th. BidaskClub cut shares of Natus Medical from a “sell” rating to a “strong sell” rating in a research report on Saturday, January 6th. William Blair cut shares of Natus Medical from an “outperform” rating to a “market perform” rating in a research report on Monday, January 8th. Finally, Zacks Investment Research downgraded Natus Medical from a “buy” rating to a “hold” rating in a report on Tuesday, December 26th. Two analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $47.00.
TRADEMARK VIOLATION WARNING: “Natus Medical Inc (BABY) Shares Sold by First Mercantile Trust Co.” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2018/02/11/natus-medical-inc-baby-shares-sold-by-first-mercantile-trust-co.html.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Inc (NASDAQ:BABY).
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.